You signed in with another tab or window. Reload to refresh your session.You signed out in another tab or window. Reload to refresh your session.You switched accounts on another tab or window. Reload to refresh your session.Dismiss alert
Image processing and microdosimetry methods for the alpha-particle dosimetry using the iQID camera, a digital autoradiography device developed by Brian Miller. This repository written by Robin Peter.
This project evaluates radiopharmaceutical dose administration in nuclear medicine procedures by comparing typical administered doses with national Diagnostic Reference Levels (DRL). The study aims to assess dose optimization practices and ensure radiation safety compliance.
Alpha-9 Oncology is a clinical-stage radiopharmaceutical company developing targeted radioligand therapies and imaging agents to treat solid and hematologic cancers with high precision.
Nuclide: total information dominance on radiopharmaceuticals. An open, cited knowledge graph of theranostics and diagnostic nuclear medicine: 811 records, static JSON API, MCP server and CLI. Forked from OnCo.
Alpha-9 Oncology — independent third-party profile of a public API surface, by API Evangelist. Alpha-9 Oncology is a clinical-stage radiopharmaceutical company that spun out of the University of British Columbia and BC Cancer in 2019 to develop a portfolio of targeted cancer therapies.
Aktis Oncology — independent third-party profile of a public API surface, by API Evangelist. Aktis Oncology is a clinical-stage biotechnology company developing next-generation precision radiopharmaceuticals for the treatment of cancer. The company has built a proprietary miniprotein radioconjugate platform that pairs tumor-targeting miniproteins w
Sinotau — independent third-party profile of a public API surface, by API Evangelist. Sinotau (先通医药) is a Chinese pharmaceutical innovator specializing in the research, development, production, clinical application, and academic promotion of radiopharmaceuticals (nuclear medicine).
Radionetics Oncology — independent third-party profile of a public API surface, by API Evangelist. Radionetics Oncology is a clinical-stage biotechnology company developing precision radiopharmaceutical treatments for cancer. The company designs small-molecule radioligands that target G-protein-coupled receptors (GPCRs) to selectively deliver targe